MRC1 and mismatch repair cancer syndrome 1: EC with probable MMR deficiency did not differ from MMR proficient EC in terms of stage, grade, LVSI, the receipt of adjuvant therapy, Mayo risk criteria, GOG 99, or PORTEC risk criteria.